Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma

doi:10.12998/wjcc.v11.i23.5416

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3987)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

2111

Figures (1-1)

256

Tables (1-1)

333

Sum=2789

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

132

Download

368

Sum=500

Publishing Process of This Article

Item

Count

Browse

155

Download

415

Sum=570

Aug 16, 2023 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Aug 16, 2023; 11(23): 5416-5429
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5416

Table 1 Role of mitokines in the prognosis of patients with hepatocellular carcinoma

Mitokines	Role in the prognosis of patients with HCC
FGF21	Negative correlation[142]
GDF15	Negative correlation[143]
Irisin	Presumed positive correlation[144]
Adropin	Not mentioned
MDPs	Not mentioned
UPRmt	Presumed negative correlation[145]

HCC: Hepatocellular carcinoma; FGF21: Fibroblast growth factor 21; GDF15: Growth differentiation factor 15; MDPs: Mitochondria-derived peptides; UPRmt: Mitochondrial unfolded protein response.

Citation: Wang J, Luo LZ, Liang DM, Guo C, Huang ZH, Jian XH, Wen J. Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma. World J Clin Cases 2023; 11(23): 5416-5429
URL: https://www.wjgnet.com/2307-8960/full/v11/i23/5416.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i23.5416